PS
HZNP

Portfolio Solutions’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Portfolio Solutions’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-300
Closed -$4K – 192
2018
Q1 		$4K Hold
300
– – ﹤0.01% 182
2017
Q4 		$4K Hold
300
– – ﹤0.01% 170
2017
Q3 		$4K Buy
+300
New +$3.81K ﹤0.01% 164

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Portfolio Solutions's HZNP Position: Q2 2018 in Review

Portfolio Solutions sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2018, closing a stake of 300 shares — an estimated $4K sold.

Portfolio Solutions first reported a position in HZNP in Q3 2017 and held it in 3 quarters. The position peaked at $4K in Q1 2018. 204 funds tracked by Wall St. Rank hold HZNP as of Q2 2018.

  • Portfolio Solutions reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2018 after selling out during the quarter.
  • Portfolio Solutions sold 300 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2018, an estimated $4K.
  • Portfolio Solutions first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2017 and held it in 3 quarters.
  • Portfolio Solutions's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4K in Q1 2018.
  • 204 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2018.

Based on Portfolio Solutions's 13F filing for Q2 2018, filed 13 Jul 2018.